Development and validation of a novel clinical decision support tool for sustained remission in Crohn’s disease: a multi-center real-world study
We developed and validated a CDST to identify CD patients likely to achieve sustained remission on IFX therapy. By stratifying patients into distinct risk profiles, it guides personalized therapy initiation and monitoring.
Authors
- Qian Cao (ORCID: https://orcid.org/0000-0002-2040-2942)
- Pingxin Zhang (ORCID: https://orcid.org/0000-0002-9064-9174)
- Chuhan Zhang (ORCID: https://orcid.org/0000-0001-8466-2797)
- Lingjie Huang (ORCID: https://orcid.org/0000-0001-9620-0629)
- Minhu Chen
- Xiang Gao
- Zicheng Huang
- Yun Qiu
- Xingrun Liu
- Kang Chao
Institutions
- Sun Yat-sen University (CN)
- Sir Run Run Shaw Hospital (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/00365521.2025.2604779
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00